awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q55269976-8D7102F5-6680-4343-8B99-0B144D88EE9B
Q55269976-8D7102F5-6680-4343-8B99-0B144D88EE9B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55269976-8D7102F5-6680-4343-8B99-0B144D88EE9B
Inhibition of the PI3K/Akt signaling pathway reverses sorafenib-derived chemo-resistance in hepatocellular carcinoma.
P2860
Q55269976-8D7102F5-6680-4343-8B99-0B144D88EE9B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55269976-8D7102F5-6680-4343-8B99-0B144D88EE9B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
935b024be7d2991db0536936579f614d67a7c654
P2860
Increasing AR by HIF-2α inhibitor (PT-2385) overcomes the side-effects of sorafenib by suppressing hepatocellular carcinoma invasion via alteration of pSTAT3, pAKT and pERK signals.